Back to results
US 2009/0156547 A1Published application
Amide prodrug of gemcitabine, compositions and use thereof
AssigneeEli Lilly And Company, an Indiana Corporation
InventorsDavid Michael Bender, David Michael Remick
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel amide prodrugs of gemcitabine, compositions thereof and methods for using.
Claims10
The compound of the formula
The compound which is 1-(2,2-difluoro-2-deoxy-β-D-ribofuranosyl)-4-(2-propyl-1-oxopentyl)aminopyrimidin-2-one p-toluenesulfonic acid co-crystal.
8-10. (canceled)
A compound which is 1-(2,2-difluoro-2-deoxy-β-D-ribofuranosyl)-4-(2-propyl-1-oxopentyl)aminopyrimidin-2-one benzenesulfonic acid co-crystal (1:1).
Dependencies are inferred from the claim text.